Yummy or too sour? Hims & Hers Health Inc (HIMS) Stock
Canaccord Genuity raised the price target for the Hims & Hers Health Inc (NYSE:HIMS) stock to “a Buy”. The rating was released on April 10, 2024, according to finviz. The research report from Leerink Partners has initiated the stock to Market Perform, with a price target set at $10. The stock was initiated by Imperial […]
Hims & Hers Health Inc (HIMS) Stock Is Emerging from the Clouds
Canaccord Genuity raised the price target for the Hims & Hers Health Inc (NYSE:HIMS) stock to “a Buy”. The rating was released on April 10, 2024, according to finviz. The research report from Leerink Partners has initiated the stock to Market Perform, with a price target set at $10. The stock was initiated by Imperial […]
The future of Hims & Hers Health Inc (HIMS) Stock is still in tatters?
Imperial Capital raised the price target for the Hims & Hers Health Inc (NYSE:HIMS) stock from “an In-line” to “an Outperform”. The rating was released on February 28, 2024, according to finviz. The research report from Imperial Capital has initiated the stock to In-line, with a price target set at $9. The stock was initiated […]
Hims & Hers Health Inc (HIMS) Stock is poised for a successful quarter
Imperial Capital raised the price target for the Hims & Hers Health Inc (NYSE:HIMS) stock from “an In-line” to “an Outperform”. The rating was released on February 28, 2024, according to finviz. The research report from Imperial Capital has initiated the stock to In-line, with a price target set at $9. The stock was initiated […]
Offering unique exposure at competitive prices: Hims & Hers Health Inc (HIMS) Stock
Imperial Capital raised the price target for the Hims & Hers Health Inc (NYSE:HIMS) stock from “an In-line” to “an Outperform”. The rating was released on February 28, 2024, according to finviz. The research report from Imperial Capital has initiated the stock to In-line, with a price target set at $9. The stock was initiated […]
The Underside Of Hims & Hers Health Inc (HIMS) Stock Is A Little Uncertain
Imperial Capital raised the price target for the Hims & Hers Health Inc (NYSE:HIMS) stock from “an In-line” to “an Outperform”. The rating was released on February 28, 2024, according to finviz. The research report from Imperial Capital has initiated the stock to In-line, with a price target set at $9. The stock was initiated […]
What does Hims & Hers Health Inc (HIMS) Stock have to offer?
Imperial Capital raised the price target for the Hims & Hers Health Inc (NYSE:HIMS) stock from “an In-line” to “an Outperform”. The rating was released on February 28, 2024, according to finviz. The research report from Imperial Capital has initiated the stock to In-line, with a price target set at $9. The stock was initiated […]
Hims & Hers Health Inc (NYSE:HIMS) stock is trading -4.88 percent below its 52-week high
Imperial Capital raised the price target for the Hims & Hers Health Inc (NYSE:HIMS) stock from “an In-line” to “an Outperform”. The rating was released on February 28, 2024, according to finviz. The research report from Imperial Capital has initiated the stock to In-line, with a price target set at $9. The stock was initiated […]
